Simple standard equation for daily step count in Japanese patients with chronic obstructive pulmonary disease

References

• Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9):972–977. doi:10.1164/rccm.200407-855OC15665324
   PubMed Web of Science ®Google Scholar
• Minakata Y, Sugino A, Kanda M, et al. Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease. Respir Investig. 2014;52(1):41–48. doi:10.1016/j.resinv.2013.06.002
   PubMedGoogle Scholar
• Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–778. doi:10.1136/thx.2006.06014516738033
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-252121273294
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Rojo B, Casitas R, et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest. 2012;142(2):338–346. doi:10.1378/chest.11-201422281798
   PubMed Web of Science ®Google Scholar
• Watz H, Krippner F, Kirsten A, Magnussen H, Vogelmeier C. Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease–a randomized, multicenter, double-blind, placebo-controlled study. BMC Pulm Med. 2014;14:158. doi:10.1186/1471-2466-14-15825280934
   PubMed Web of Science ®Google Scholar
• Beeh KM, Watz H, Puente-Maestu L, et al. Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial. BMC Pulm Med. 2014;14(1):209. doi:10.1186/1471-2466-14-20925539654
   PubMed Web of Science ®Google Scholar
• Minakata Y, Morishita Y, Ichikawa T, et al. Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:1275–1282. doi:10.2147/COPD.S8413426170656
   PubMed Web of Science ®Google Scholar
• O’Donnell DE, Casaburi R, Vincken W, et al. Effect of indacaterol on exercise endurance and lung hyperinflation in COPD. Respir Med. 2011;105(7):1030–1036. doi:10.1016/j.rmed.2011.03.01421498063
   PubMed Web of Science ®Google Scholar
• Troosters T, Sciurba FC, Decramer M, et al. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial. NPJ Prim Care Respir Med. 2014;24:14003. doi:10.1038/npjpcrm.2014.324841833
   PubMed Web of Science ®Google Scholar
• Griffiths TL, Burr ML, Campbell IA, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355(9201):362–368. doi:10.1016/s0140-6736(99)07042-710665556
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest. 2008;134(2):273–280. doi:10.1378/chest.07-265518403667
   PubMed Web of Science ®Google Scholar
• Mador MJ, Patel AN, Nadler J. Effects of pulmonary rehabilitation on activity levels in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil Prev. 2011;31(1):52–59. doi:10.1097/HCR.0b013e3181ebf2ef20724933
   PubMed Web of Science ®Google Scholar
• Mendoza L, Horta P, Espinoza J, et al. Pedometers to enhance physical activity in COPD: a randomised controlled trial. Eur Respir J. 2015;45(2):347–354. doi:10.1183/09031936.0008451425261324
   PubMed Web of Science ®Google Scholar
• Shioya T, Sato S, Iwakura M, et al. Improvement of physical activity in chronic obstructive pulmonary disease by pulmonary rehabilitation and pharmacological treatment. Respir Investig. 2018;56(4):292–306. doi:10.1016/j.resinv.2018.05.002
   PubMed Web of Science ®Google Scholar
• Altenburg WA, Ten Hacken NH, Bossenbroek L, Kerstjens HA, de Greef MH, Wempe JB. Short- and long-term effects of a physical activity counselling programme in COPD: a randomized controlled trial. Respir Med. 2015;109(1):112–121. doi:10.1016/j.rmed.2014.10.02025499548
   PubMed Web of Science ®Google Scholar
• Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American college of sports medicine and the American heart association. Circulation. 2007;116(9):1094–1105. doi:10.1161/CIRCULATIONAHA.107.18565017671236
   PubMed Web of Science ®Google Scholar
• Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi:10.1183/09031936.0004681425359358
   PubMed Web of Science ®Google Scholar
• Sugino A, Minakata Y, Kanda M, et al. Validation of a compact motion sensor for the measurement of physical activity in patients with chronic obstructive pulmonary disease. Respiration. 2012;83(4):300–307. doi:10.1159/00033004621912085
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Minakata Y, Azuma Y, et al. Verification of a motion sensor for evaluating physical activity in COPD patients. Can Respir J. 2018;2018:8343705. doi:10.1155/2018/834370529849834
   PubMed Web of Science ®Google Scholar
• Rabinovich RA, Louvaris Z, Raste Y, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J. 2013;42(5):1205–1215. doi:10.1183/09031936.0013431223397303
   PubMed Web of Science ®Google Scholar
• Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33(2):262–272. doi:10.1183/09031936.0002460819010994
   PubMed Web of Science ®Google Scholar
• Byrom B, Rowe DA. Measuring free-living physical activity in COPD patients: deriving methodology standards for clinical trials through a review of research studies. Contemp Clin Trials. 2016;47:172–184. doi:10.1016/j.cct.2016.01.00626806669
   PubMed Web of Science ®Google Scholar
• Hernandes NA, Teixeira Dde C, Probst VS, Brunetto AF, Ramos EM, Pitta F. Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J Bras Pneumol. 2009;35(10):949–956. doi:10.1590/s1806-3713200900100000219918626
   PubMed Web of Science ®Google Scholar
• Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner DM. Quantitating physical activity in COPD using a triaxial accelerometer. Chest. 2000;117(5):1359–1367. doi:10.1378/chest.117.5.135910807823
   PubMed Web of Science ®Google Scholar
• Waschki B, Spruit MA, Watz H, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med. 2012;106(4):522–530. doi:10.1016/j.rmed.2011.10.02222118987
   PubMed Web of Science ®Google Scholar
• Walker PP, Burnett A, Flavahan PW, Calverley PM. Lower limb activity and its determinants in COPD. Thorax. 2008;63(8):683–689. doi:10.1136/thx.2007.08713018487318
   PubMed Web of Science ®Google Scholar
• Hayata A, Minakata Y, Matsunaga K, Nakanishi M, Yamamoto N. Differences in physical activity according to mMRC grade in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2203–2208. doi:10.2147/COPD.S10969427695306
   PubMed Web of Science ®Google Scholar
• Saunders T, Campbell N, Jason T, et al. Objectively measured steps/day in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Phys Act Health. 2016;13(11):1275–1283. doi:10.1123/jpah.2016-008727334811
   PubMed Web of Science ®Google Scholar
• Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Vercoulen JH, Heijdra YF. Resting and ADL-induced dynamic hyperinflation explain physical inactivity in COPD better than FEV1. Respir Med. 2013;107(6):834–840. doi:10.1016/j.rmed.2013.02.01723514950
   PubMed Web of Science ®Google Scholar
• Althoff T, Sosic R, Hicks JL, King AC, Delp SL, Leskovec J. Large-scale physical activity data reveal worldwide activity inequality. Nature. 2017;547(7663):336–339. doi:10.1038/nature2301828693034
   PubMed Web of Science ®Google Scholar
• National Institute of Health and Nutrition. The National Health and Nutrition Survey in Japan 2017. Tokyo, Japan, 2018 (in Japanese). Available from: https://www.mhlw.go.jp/content/000451758.pdf. Accessed January 7, 2019
   Google Scholar
• National Institute of Health and Nutrition. Table 5, (2) Physical activity and exercise in List of Targets, Health Japan 21 (the second term), Tokyo, Japan. Available from: https://www.nibiohn.go.jp/eiken/kenkounippon21/en/kenkounippon21/mokuhyou05.html. Accessed January 7, 2019.
   Google Scholar
• Hataji O, Naito M, Ito K, Watanabe F , Gabazza EC, Taguchi O. Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:1–5. doi:10.2147/COPD.S3854823293514
   PubMed Web of Science ®Google Scholar
• Portal Site of Official Statistics of Japan (S-Stat). Patient Survey 2017 (in Japanese), Tokyo, Japan, 2019. Available from: https://www.e-stat.go.jp/dbview?sid=0003318584. Accessed 17, 2019.
   Google Scholar
• Landis SH, Muellerova H, Mannino DM, et al. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611. doi:10.2147/COPD.S6185424944511
   PubMed Web of Science ®Google Scholar
• Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the nippon COPD epidemiology study. Respirology. 2004;9(4):458–465. doi:10.1111/j.1440-1843.2004.00637.x15612956
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Seki N, Fukuyama S, et al. Prevalence of asthma with airflow limitation, COPD, and COPD with variable airflow limitation in older subjects in a general Japanese population: the Hisayama study. Respir Investig. 2015;53(1):22–29. doi:10.1016/j.resinv.2014.08.002
   PubMed Web of Science ®Google Scholar
• Ishii T, Nishimura M, Akimoto A, James MH, Jones P. Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries. Int J Chron Obstruct Pulmon Dis. 2018;13:3459–3471. doi:10.2147/COPD.S16518730464435
   PubMed Web of Science ®Google Scholar
• Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, et al. Benefits of physical activity on COPD hospitalisation depend on intensity. Eur Respir J. 2015;46(5):1281–1289. doi:10.1183/13993003.01699-201426206873
   PubMed Web of Science ®Google Scholar